{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T13:01:00Z","timestamp":1790168460441,"version":"4.1.0"},"reference-count":132,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Guangxi Natural Science Foundation for Distinguished Young Scholars","award":["2022GXNSFFA035026"],"award-info":[{"award-number":["2022GXNSFFA035026"]}]},{"name":"Guangxi Science and Technology Major Program","award":["\uff08Guike AA24263028\uff09 \uff08Guike AA24011004\uff09"],"award-info":[{"award-number":["\uff08Guike AA24263028\uff09 \uff08Guike AA24011004\uff09"]}]},{"name":"Guangxi Key Technologies R&D Program","award":["Guike AB23026058"],"award-info":[{"award-number":["Guike AB23026058"]}]},{"name":"the Scientific and Technological Innovation Major Base of Guangxi","award":["No.2022-36-Z05"],"award-info":[{"award-number":["No.2022-36-Z05"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-026-04340-6","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T18:10:52Z","timestamp":1777572652000},"page":"4491-4510","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ferroptosis in cancer: molecular mechanisms, biological roles, and therapeutic significance"],"prefix":"10.1007","volume":"28","author":[{"given":"Honghua","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jintong","family":"Na","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jijie","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyi","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yupei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongxiang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8624-3091","authenticated-orcid":false,"given":"Liping","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,30]]},"reference":[{"issue":"7","key":"4340_CR1","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1016\/j.ymthe.2021.03.022","volume":"29","author":"H Wang","year":"2021","unstructured":"Wang H, et al. Emerging mechanisms and targeted therapy of ferroptosis in cancer. Mol Ther. 2021;29(7):2185\u2013208.","journal-title":"Mol Ther"},{"issue":"2","key":"4340_CR2","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/cac2.12250","volume":"42","author":"L Zhao","year":"2022","unstructured":"Zhao L, et al. Ferroptosis in cancer and cancer immunotherapy. Cancer Commun (Lond). 2022;42(2):88\u2013116.","journal-title":"Cancer Commun (Lond)"},{"issue":"5","key":"4340_CR3","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060\u201372.","journal-title":"Cell"},{"key":"4340_CR4","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s40364-020-00229-w","volume":"8","author":"S Zuo","year":"2020","unstructured":"Zuo S, et al. Novel insights on targeting ferroptosis in cancer therapy. Biomark Res. 2020;8:50.","journal-title":"Biomark Res"},{"key":"4340_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26083852","author":"M Singh","year":"2025","unstructured":"Singh M, et al. Ferroptosis in Cancer: Mechanism and Therapeutic Potential. Int J Mol Sci. 2025. https:\/\/doi.org\/10.3390\/ijms26083852.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4340_CR6","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s13045-022-01392-3","volume":"15","author":"X Tong","year":"2022","unstructured":"Tong X, et al. Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research. J Hematol Oncol. 2022;15(1):174.","journal-title":"J Hematol Oncol"},{"issue":"8","key":"4340_CR7","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.tips.2023.06.005","volume":"44","author":"R Kim","year":"2023","unstructured":"Kim R, et al. Ferroptosis of immune cells in the tumor microenvironment. Trends Pharmacol Sci. 2023;44(8):542\u201352.","journal-title":"Trends Pharmacol Sci"},{"key":"4340_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2023.108373","volume":"244","author":"I Costa","year":"2023","unstructured":"Costa I, et al. Molecular mechanisms of ferroptosis and their involvement in brain diseases. Pharmacol Ther. 2023;244:108373.","journal-title":"Pharmacol Ther"},{"issue":"14","key":"4340_CR9","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1016\/j.cell.2022.06.003","volume":"185","author":"BR Stockwell","year":"2022","unstructured":"Stockwell BR. Ferroptosis turns 10: emerging mechanisms, physiological functions, and therapeutic applications. Cell. 2022;185(14):2401\u201321.","journal-title":"Cell"},{"issue":"10","key":"4340_CR10","doi-asserted-by":"publisher","first-page":"5866","DOI":"10.1021\/cr200246d","volume":"111","author":"JZ Haeggstr\u00f6m","year":"2011","unstructured":"Haeggstr\u00f6m JZ, Funk CD. Lipoxygenase and leukotriene pathways: biochemistry, biology, and roles in disease. Chem Rev. 2011;111(10):5866\u201398.","journal-title":"Chem Rev"},{"issue":"12","key":"4340_CR11","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1016\/j.tcb.2023.05.003","volume":"33","author":"LE Pope","year":"2023","unstructured":"Pope LE, Dixon SJ. Regulation of ferroptosis by lipid metabolism. Trends Cell Biol. 2023;33(12):1077\u201387.","journal-title":"Trends Cell Biol"},{"key":"4340_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102650","volume":"61","author":"YY Tyurina","year":"2023","unstructured":"Tyurina YY, et al. Redox phospholipidomics discovers pro-ferroptotic death signals in A375 melanoma cells in vitro and in vivo. Redox Biol. 2023;61:102650.","journal-title":"Redox Biol"},{"issue":"4","key":"4340_CR13","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"X Jiang","year":"2021","unstructured":"Jiang X, Stockwell BR, Conrad M. Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol. 2021;22(4):266\u201382.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"11","key":"4340_CR14","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/s41419-019-2064-5","volume":"10","author":"E Park","year":"2019","unstructured":"Park E, Chung SW. ROS-mediated autophagy increases intracellular iron levels and ferroptosis by ferritin and transferrin receptor regulation. Cell Death Dis. 2019;10(11):822.","journal-title":"Cell Death Dis"},{"issue":"5","key":"4340_CR15","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/s41589-018-0031-6","volume":"14","author":"MM Gaschler","year":"2018","unstructured":"Gaschler MM, et al. FINO(2) initiates ferroptosis through GPX4 inactivation and iron oxidation. Nat Chem Biol. 2018;14(5):507\u201315.","journal-title":"Nat Chem Biol"},{"issue":"1","key":"4340_CR16","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40880-018-0288-x","volume":"38","author":"P Koppula","year":"2018","unstructured":"Koppula P, et al. Amino acid transporter SLC7A11\/xCT at the crossroads of regulating redox homeostasis and nutrient dependency of cancer. Cancer Commun (Lond). 2018;38(1):12.","journal-title":"Cancer Commun (Lond)"},{"issue":"12","key":"4340_CR17","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/s41419-023-06359-x","volume":"14","author":"H Zhu","year":"2023","unstructured":"Zhu H, et al. Gss deficiency causes age-related fertility impairment via ROS-triggered ferroptosis in the testes of mice. Cell Death Dis. 2023;14(12):845.","journal-title":"Cell Death Dis"},{"issue":"1","key":"4340_CR18","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1038\/s41467-022-29905-1","volume":"13","author":"P Koppula","year":"2022","unstructured":"Koppula P, et al. A targetable CoQ-FSP1 axis drives ferroptosis- and radiation-resistance in KEAP1 inactive lung cancers. Nat Commun. 2022;13(1):2206.","journal-title":"Nat Commun"},{"issue":"21","key":"4340_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202416149","volume":"12","author":"K Sun","year":"2025","unstructured":"Sun K, et al. Glycolysis-derived lactate induces ACSL4 expression and lactylation to activate ferroptosis during intervertebral disc degeneration. Adv Sci (Weinh). 2025;12(21):e2416149.","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"4340_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02198-2","volume":"24","author":"MA Freitas-Cortez","year":"2025","unstructured":"Freitas-Cortez MA, et al. Cancer cells avoid ferroptosis induced by immune cells via fatty acid binding proteins. Mol Cancer. 2025;24(1):40.","journal-title":"Mol Cancer"},{"key":"4340_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102276","volume":"51","author":"J Lee","year":"2022","unstructured":"Lee J, You JH, Roh JL. Poly(rC)-binding protein 1 represses ferritinophagy-mediated ferroptosis in head and neck cancer. Redox Biol. 2022;51:102276.","journal-title":"Redox Biol"},{"issue":"3","key":"4340_CR22","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.cmet.2008.07.005","volume":"8","author":"A Seiler","year":"2008","unstructured":"Seiler A, et al. Glutathione peroxidase 4 senses and translates oxidative stress into 12\/15-lipoxygenase dependent- and AIF-mediated cell death. Cell Metab. 2008;8(3):237\u201348.","journal-title":"Cell Metab"},{"issue":"1","key":"4340_CR23","doi-asserted-by":"publisher","first-page":"10107","DOI":"10.1038\/s41467-024-54435-3","volume":"15","author":"K G\u0142owacka","year":"2024","unstructured":"G\u0142owacka K, et al. Acid-exposed and hypoxic cancer cells do not overlap but are interdependent for unsaturated fatty acid resources. Nat Commun. 2024;15(1):10107.","journal-title":"Nat Commun"},{"issue":"7746","key":"4340_CR24","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/s41586-019-0945-5","volume":"567","author":"J Garcia-Bermudez","year":"2019","unstructured":"Garcia-Bermudez J, et al. Squalene accumulation in cholesterol auxotrophic lymphomas prevents oxidative cell death. Nature. 2019;567(7746):118\u201322.","journal-title":"Nature"},{"issue":"9","key":"4340_CR25","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s13238-021-00823-0","volume":"12","author":"P Koppula","year":"2021","unstructured":"Koppula P, Zhuang L, Gan B. Cytochrome P450 reductase (POR) as a ferroptosis fuel. Protein Cell. 2021;12(9):675\u20139.","journal-title":"Protein Cell"},{"issue":"7682","key":"4340_CR26","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/nature24637","volume":"551","author":"SW Alvarez","year":"2017","unstructured":"Alvarez SW, et al. NFS1 undergoes positive selection in lung tumours and protects cells from ferroptosis. Nature. 2017;551(7682):639\u201343.","journal-title":"Nature"},{"key":"4340_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2020.101670","volume":"36","author":"DC Fuhrmann","year":"2020","unstructured":"Fuhrmann DC, et al. Hypoxia inhibits ferritinophagy, increases mitochondrial ferritin, and protects from ferroptosis. Redox Biol. 2020;36:101670.","journal-title":"Redox Biol"},{"issue":"6","key":"4340_CR28","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.ccell.2023.05.001","volume":"41","author":"JK Minami","year":"2023","unstructured":"Minami JK, et al. CDKN2A deletion remodels lipid metabolism to prime glioblastoma for ferroptosis. Cancer Cell. 2023;41(6):1048-1060.e9.","journal-title":"Cancer Cell"},{"issue":"1","key":"4340_CR29","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s40164-023-00468-1","volume":"13","author":"CH Williams","year":"2024","unstructured":"Williams CH, et al. GPR68-ATF4 signaling is a novel prosurvival pathway in glioblastoma activated by acidic extracellular microenvironment. Exp Hematol Oncol. 2024;13(1):13.","journal-title":"Exp Hematol Oncol"},{"issue":"7545","key":"4340_CR30","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature14344","volume":"520","author":"L Jiang","year":"2015","unstructured":"Jiang L, et al. Ferroptosis as a p53-mediated activity during tumour suppression. Nature. 2015;520(7545):57\u201362.","journal-title":"Nature"},{"issue":"5","key":"4340_CR31","doi-asserted-by":"publisher","first-page":"9585","DOI":"10.1126\/sciadv.ade9585","volume":"9","author":"A Anandhan","year":"2023","unstructured":"Anandhan A, et al. NRF2 controls iron homeostasis and ferroptosis through HERC2 and VAMP8. Sci Adv. 2023;9(5):9585.","journal-title":"Sci Adv"},{"issue":"8","key":"4340_CR32","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1038\/s41418-017-0053-8","volume":"25","author":"M Luo","year":"2018","unstructured":"Luo M, et al. miR-137 regulates ferroptosis by targeting glutamine transporter SLC1A5 in melanoma. Cell Death Differ. 2018;25(8):1457\u201372.","journal-title":"Cell Death Differ"},{"issue":"2","key":"4340_CR33","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/0005-2760(82)90150-3","volume":"710","author":"F Ursini","year":"1982","unstructured":"Ursini F, et al. Purification from pig liver of a protein which protects liposomes and biomembranes from peroxidative degradation and exhibits glutathione peroxidase activity on phosphatidylcholine hydroperoxides. Biochim Biophys Acta. 1982;710(2):197\u2013211.","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"4340_CR34","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1042\/BST20220682","volume":"50","author":"T Nishida Xavier da Silva","year":"2022","unstructured":"Nishida Xavier da Silva T, Friedmann Angeli JP, Ingold I. GPX4: old lessons, new features. Biochem Soc Trans. 2022;50(3):1205\u201313.","journal-title":"Biochem Soc Trans"},{"issue":"2","key":"4340_CR35","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","volume":"171","author":"BR Stockwell","year":"2017","unstructured":"Stockwell BR, et al. Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease. Cell. 2017;171(2):273\u201385.","journal-title":"Cell"},{"issue":"17","key":"4340_CR36","doi-asserted-by":"publisher","first-page":"11455","DOI":"10.1074\/jbc.274.17.11455","volume":"274","author":"H Sato","year":"1999","unstructured":"Sato H, et al. Cloning and expression of a plasma membrane cystine\/glutamate exchange transporter composed of two distinct proteins. J Biol Chem. 1999;274(17):11455\u20138.","journal-title":"J Biol Chem"},{"issue":"8","key":"4340_CR37","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s13238-020-00789-5","volume":"12","author":"P Koppula","year":"2021","unstructured":"Koppula P, Zhuang L, Gan B. Cystine transporter SLC7A11\/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy. Protein Cell. 2021;12(8):599\u2013620.","journal-title":"Protein Cell"},{"issue":"15","key":"4340_CR38","doi-asserted-by":"publisher","first-page":"3877","DOI":"10.1158\/0008-5472.CAN-18-3855","volume":"79","author":"B Daher","year":"2019","unstructured":"Daher B, et al. Genetic ablation of the cystine transporter xCT in PDAC cells inhibits mTORC1, growth, survival, and tumor formation via nutrient and oxidative stresses. Cancer Res. 2019;79(15):3877\u201390.","journal-title":"Cancer Res"},{"issue":"7","key":"4340_CR39","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1021\/acschembio.5b00245","volume":"10","author":"SJ Dixon","year":"2015","unstructured":"Dixon SJ, et al. Human Haploid Cell Genetics Reveals Roles for Lipid Metabolism Genes in Nonapoptotic Cell Death. ACS Chem Biol. 2015;10(7):1604\u20139.","journal-title":"ACS Chem Biol"},{"issue":"10","key":"4340_CR40","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.trecan.2022.04.002","volume":"8","author":"O Kepp","year":"2022","unstructured":"Kepp O, Kroemer G. Pro-ferroptotic fatty acid metabolism renders cancer cells immunogenic. Trends Cancer. 2022;8(10):785\u20137.","journal-title":"Trends Cancer"},{"issue":"1","key":"4340_CR41","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nchembio.2239","volume":"13","author":"S Doll","year":"2017","unstructured":"Doll S, et al. ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. Nat Chem Biol. 2017;13(1):91\u20138.","journal-title":"Nat Chem Biol"},{"issue":"4","key":"4340_CR42","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.ccell.2022.02.003","volume":"40","author":"P Liao","year":"2022","unstructured":"Liao P, et al. CD8(+) T cells and fatty acids orchestrate tumor ferroptosis and immunity via ACSL4. Cancer Cell. 2022;40(4):365-378.e6.","journal-title":"Cancer Cell"},{"issue":"6","key":"4340_CR43","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1021\/acschembio.2c00317","volume":"17","author":"A Reed","year":"2022","unstructured":"Reed A, et al. LPCAT3 inhibitors remodel the polyunsaturated phospholipid content of human cells and protect from ferroptosis. ACS Chem Biol. 2022;17(6):1607\u201318.","journal-title":"ACS Chem Biol"},{"issue":"7\u20139","key":"4340_CR44","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1089\/ars.2023.0237","volume":"39","author":"J Cui","year":"2023","unstructured":"Cui J, et al. LPCAT3 is transcriptionally regulated by YAP\/ZEB\/EP300 and collaborates with ACSL4 and YAP to determine ferroptosis sensitivity. Antioxid Redox Signal. 2023;39(7\u20139):491\u2013511.","journal-title":"Antioxid Redox Signal"},{"issue":"5","key":"4340_CR45","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.molcel.2020.10.010","volume":"80","author":"N Takahashi","year":"2020","unstructured":"Takahashi N, et al. 3D culture models with CRISPR screens reveal hyperactive NRF2 as a prerequisite for spheroid formation via regulation of proliferation and ferroptosis. Mol Cell. 2020;80(5):828-844.e6.","journal-title":"Mol Cell"},{"issue":"6","key":"4340_CR46","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.tips.2013.04.005","volume":"34","author":"T Suzuki","year":"2013","unstructured":"Suzuki T, Motohashi H, Yamamoto M. Toward clinical application of the Keap1-Nrf2 pathway. Trends Pharmacol Sci. 2013;34(6):340\u20136.","journal-title":"Trends Pharmacol Sci"},{"key":"4340_CR47","doi-asserted-by":"publisher","first-page":"101107","DOI":"10.1016\/j.redox.2019.101107","volume":"23","author":"M Dodson","year":"2019","unstructured":"Dodson M, Castro-Portuguez R, Zhang DD. NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis. Redox Biol. 2019;23:101107.","journal-title":"Redox Biol"},{"issue":"13","key":"4340_CR48","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1158\/0008-5472.CAN-24-2745","volume":"85","author":"U Sen","year":"2025","unstructured":"Sen U, et al. SCD1 inhibition blocks the AKT-NRF2-SLC7A11 pathway to induce lipid metabolism remodeling and ferroptosis priming in lung adenocarcinoma. Cancer Res. 2025;85(13):2485\u2013503.","journal-title":"Cancer Res"},{"key":"4340_CR49","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.freeradbiomed.2018.10.426","volume":"129","author":"D Shin","year":"2018","unstructured":"Shin D, et al. Nrf2 inhibition reverses resistance to GPX4 inhibitor-induced ferroptosis in head and neck cancer. Free Radic Biol Med. 2018;129:454\u201362.","journal-title":"Free Radic Biol Med"},{"issue":"11","key":"4340_CR50","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1158\/2159-8290.CD-24-0837","volume":"14","author":"H Song","year":"2024","unstructured":"Song H, et al. Drugging p53: barriers, criteria, and prospects. Cancer Discov. 2024;14(11):2055\u201360.","journal-title":"Cancer Discov"},{"key":"4340_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2020.101619","volume":"36","author":"Z Zhang","year":"2020","unstructured":"Zhang Z, et al. The BRD7-P53-SLC25A28 axis regulates ferroptosis in hepatic stellate cells. Redox Biol. 2020;36:101619.","journal-title":"Redox Biol"},{"issue":"2","key":"4340_CR52","doi-asserted-by":"publisher","first-page":"403","DOI":"10.3324\/haematol.2020.259531","volume":"107","author":"R Birsen","year":"2022","unstructured":"Birsen R, et al. APR-246 induces early cell death by ferroptosis in acute myeloid leukemia. Haematologica. 2022;107(2):403\u201316.","journal-title":"Haematologica"},{"issue":"4","key":"4340_CR53","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/s41571-024-00868-0","volume":"21","author":"JM Llovet","year":"2024","unstructured":"Llovet JM, et al. Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma. Nat Rev Clin Oncol. 2024;21(4):294\u2013311.","journal-title":"Nat Rev Clin Oncol"},{"key":"4340_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.155135","volume":"122","author":"R Yang","year":"2024","unstructured":"Yang R, et al. Polyphyllin I induced ferroptosis to suppress the progression of hepatocellular carcinoma through activation of the mitochondrial dysfunction via Nrf2\/HO-1\/GPX4 axis. Phytomedicine. 2024;122:155135.","journal-title":"Phytomedicine"},{"issue":"1","key":"4340_CR55","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41418-022-01051-7","volume":"30","author":"Q Chen","year":"2023","unstructured":"Chen Q, et al. SOCS2-enhanced ubiquitination of SLC7A11 promotes ferroptosis and radiosensitization in hepatocellular carcinoma. Cell Death Differ. 2023;30(1):137\u201351.","journal-title":"Cell Death Differ"},{"issue":"22","key":"4340_CR56","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202206798","volume":"10","author":"C Zheng","year":"2023","unstructured":"Zheng C, et al. Donafenib and GSK-J4 Synergistically Induce Ferroptosis in Liver Cancer by Upregulating HMOX1 Expression. Adv Sci (Weinh). 2023;10(22):e2206798.","journal-title":"Adv Sci (Weinh)"},{"issue":"20","key":"4340_CR57","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1056\/NEJMra1001389","volume":"363","author":"WD Foulkes","year":"2010","unstructured":"Foulkes WD, Smith IE, Reis-Filho JS. Triple-negative breast cancer. N Engl J Med. 2010;363(20):1938\u201348.","journal-title":"N Engl J Med"},{"issue":"2","key":"4340_CR58","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1158\/2159-8290.CD-18-1177","volume":"9","author":"AC Garrido-Castro","year":"2019","unstructured":"Garrido-Castro AC, Lin NU, Polyak K. Insights into molecular classifications of triple-negative breast cancer: improving patient selection for treatment. Cancer Discov. 2019;9(2):176\u201398.","journal-title":"Cancer Discov"},{"issue":"1","key":"4340_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101915","volume":"6","author":"Y Liu","year":"2025","unstructured":"Liu Y, et al. Dual ferroptosis induction in N2-TANs and TNBC cells via FTH1 targeting: a therapeutic strategy for triple-negative breast cancer. Cell Rep Med. 2025;6(1):101915.","journal-title":"Cell Rep Med"},{"issue":"1","key":"4340_CR60","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.cmet.2022.09.021","volume":"35","author":"F Yang","year":"2023","unstructured":"Yang F, et al. Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy. Cell Metab. 2023;35(1):84-100.e8.","journal-title":"Cell Metab"},{"issue":"10242","key":"4340_CR61","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1016\/S0140-6736(20)30974-0","volume":"395","author":"JD Mizrahi","year":"2020","unstructured":"Mizrahi JD, et al. Pancreatic cancer. Lancet. 2020;395(10242):2008\u201320.","journal-title":"Lancet"},{"issue":"720","key":"4340_CR62","doi-asserted-by":"publisher","first-page":"eadg3049","DOI":"10.1126\/scitranslmed.adg3049","volume":"15","author":"J Li","year":"2023","unstructured":"Li J, et al. Tumor-specific GPX4 degradation enhances ferroptosis-initiated antitumor immune response in mouse models of pancreatic cancer. Sci Transl Med. 2023;15(720):eadg3049.","journal-title":"Sci Transl Med"},{"issue":"1","key":"4340_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24859-2","volume":"12","author":"DM Kremer","year":"2021","unstructured":"Kremer DM, et al. GOT1 inhibition promotes pancreatic cancer cell death by ferroptosis. Nat Commun. 2021;12(1):4860.","journal-title":"Nat Commun"},{"key":"4340_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216826","volume":"590","author":"GB Gao","year":"2024","unstructured":"Gao GB, et al. LncRNA RGMB-AS1 inhibits HMOX1 ubiquitination and NAA10 activation to induce ferroptosis in non-small cell lung cancer. Cancer Lett. 2024;590:216826.","journal-title":"Cancer Lett"},{"issue":"1","key":"4340_CR65","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41418-023-01239-5","volume":"31","author":"Z Wang","year":"2024","unstructured":"Wang Z, et al. TRIM3 facilitates ferroptosis in non-small cell lung cancer through promoting SLC7A11\/xCT K11-linked ubiquitination and degradation. Cell Death Differ. 2024;31(1):53\u201364.","journal-title":"Cell Death Differ"},{"issue":"3","key":"4340_CR66","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"4340_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103087","volume":"71","author":"H Li","year":"2024","unstructured":"Li H, et al. METTL17 coordinates ferroptosis and tumorigenesis by regulating mitochondrial translation in colorectal cancer. Redox Biol. 2024;71:103087.","journal-title":"Redox Biol"},{"issue":"11","key":"4340_CR68","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.7150\/ijbs.59404","volume":"17","author":"R Wei","year":"2021","unstructured":"Wei R, et al. Tagitinin C induces ferroptosis through PERK-Nrf2-HO-1 signaling pathway in colorectal cancer cells. Int J Biol Sci. 2021;17(11):2703\u201317.","journal-title":"Int J Biol Sci"},{"issue":"2","key":"4340_CR69","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.immuni.2018.01.007","volume":"48","author":"BV Kumar","year":"2018","unstructured":"Kumar BV, Connors TJ, Farber DL. Human T cell development, localization, and function throughout life. Immunity. 2018;48(2):202\u201313.","journal-title":"Immunity"},{"issue":"4","key":"4340_CR70","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1084\/jem.20140857","volume":"212","author":"M Matsushita","year":"2015","unstructured":"Matsushita M, et al. T cell lipid peroxidation induces ferroptosis and prevents immunity to infection. J Exp Med. 2015;212(4):555\u201368.","journal-title":"J Exp Med"},{"issue":"12","key":"4340_CR71","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1158\/2159-8290.CD-19-0338","volume":"9","author":"X Lang","year":"2019","unstructured":"Lang X, et al. Radiotherapy and immunotherapy promote tumoral lipid oxidation and ferroptosis via synergistic repression of SLC7A11. Cancer Discov. 2019;9(12):1673\u201385.","journal-title":"Cancer Discov"},{"issue":"4","key":"4340_CR72","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.ccell.2022.03.003","volume":"40","author":"JP Friedmann Angeli","year":"2022","unstructured":"Friedmann Angeli JP, Xavier da Silva TN, Schilling B. CD8(+) T cells PUF(A)ing the flames of cancer ferroptotic cell death. Cancer Cell. 2022;40(4):346\u20138.","journal-title":"Cancer Cell"},{"issue":"8","key":"4340_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.labinv.2023.100180","volume":"103","author":"Y Li","year":"2023","unstructured":"Li Y, et al. MAT1A Suppression by the CTBP1\/HDAC1\/HDAC2 Transcriptional Complex Induces Immune Escape and Reduces Ferroptosis in Hepatocellular Carcinoma. Lab Invest. 2023;103(8):100180.","journal-title":"Lab Invest"},{"issue":"4","key":"4340_CR74","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/s41568-019-0235-4","volume":"20","author":"AM van der Leun","year":"2020","unstructured":"van der Leun AM, Thommen DS, Schumacher TN. CD8(+) T cell states in human cancer: insights from single-cell analysis. Nat Rev Cancer. 2020;20(4):218\u201332.","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"4340_CR75","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/s41577-019-0232-6","volume":"20","author":"C Raffin","year":"2020","unstructured":"Raffin C, Vo LT, Bluestone JA. T(reg) cell-based therapies: challenges and perspectives. Nat Rev Immunol. 2020;20(3):158\u201372.","journal-title":"Nat Rev Immunol"},{"issue":"11","key":"4340_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109235","volume":"35","author":"C Xu","year":"2021","unstructured":"Xu C, et al. The glutathione peroxidase Gpx4 prevents lipid peroxidation and ferroptosis to sustain Treg cell activation and suppression of antitumor immunity. Cell Rep. 2021;35(11):109235.","journal-title":"Cell Rep"},{"issue":"1","key":"4340_CR77","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s13046-022-02327-z","volume":"41","author":"K Pan","year":"2022","unstructured":"Pan K, et al. CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy. J Exp Clin Cancer Res. 2022;41(1):119.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"4340_CR78","doi-asserted-by":"publisher","first-page":"54","DOI":"10.7150\/jca.49692","volume":"12","author":"S Zhu","year":"2021","unstructured":"Zhu S, et al. Tumor-associated macrophages: role in tumorigenesis and immunotherapy implications. J Cancer. 2021;12(1):54\u201364.","journal-title":"J Cancer"},{"issue":"3","key":"4340_CR79","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/s41589-019-0462-8","volume":"16","author":"AA Kapralov","year":"2020","unstructured":"Kapralov AA, et al. Redox lipid reprogramming commands susceptibility of macrophages and microglia to ferroptotic death. Nat Chem Biol. 2020;16(3):278\u201390.","journal-title":"Nat Chem Biol"},{"issue":"18","key":"4340_CR80","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202207650","volume":"10","author":"Y He","year":"2023","unstructured":"He Y, et al. The Combination of R848 with Sorafenib Enhances Antitumor Effects by Reprogramming the Tumor Immune Microenvironment and Facilitating Vascular Normalization in Hepatocellular Carcinoma. Adv Sci (Weinh). 2023;10(18):e2207650.","journal-title":"Adv Sci (Weinh)"},{"issue":"8","key":"4340_CR81","doi-asserted-by":"publisher","DOI":"10.1172\/JCI139434","volume":"131","author":"Z Jiang","year":"2021","unstructured":"Jiang Z, et al. TYRO3 induces anti-PD-1\/PD-L1 therapy resistance by limiting innate immunity and tumoral ferroptosis. J Clin Invest. 2021;131(8):e139434.","journal-title":"J Clin Invest"},{"issue":"7","key":"4340_CR82","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1093\/neuonc\/noac033","volume":"24","author":"T Liu","year":"2022","unstructured":"Liu T, et al. Ferroptosis, as the most enriched programmed cell death process in glioma, induces immunosuppression and immunotherapy resistance. Neuro Oncol. 2022;24(7):1113\u201325.","journal-title":"Neuro Oncol"},{"issue":"1","key":"4340_CR83","doi-asserted-by":"publisher","first-page":"6339","DOI":"10.1038\/s41467-020-20154-8","volume":"11","author":"E Dai","year":"2020","unstructured":"Dai E, et al. Ferroptotic damage promotes pancreatic tumorigenesis through a TMEM173\/STING-dependent DNA sensor pathway. Nat Commun. 2020;11(1):6339.","journal-title":"Nat Commun"},{"issue":"3","key":"4340_CR84","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/s41577-021-00571-6","volume":"22","author":"CC Hedrick","year":"2022","unstructured":"Hedrick CC, Malanchi I. Neutrophils in cancer: heterogeneous and multifaceted. Nat Rev Immunol. 2022;22(3):173\u201387.","journal-title":"Nat Rev Immunol"},{"issue":"7","key":"4340_CR85","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/nrc.2016.52","volume":"16","author":"SB Coffelt","year":"2016","unstructured":"Coffelt SB, Wellenstein MD, de Visser KE. Neutrophils in cancer: neutral no more. Nat Rev Cancer. 2016;16(7):431\u201346.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"4340_CR86","doi-asserted-by":"publisher","first-page":"5424","DOI":"10.1038\/s41467-020-19193-y","volume":"11","author":"PP Yee","year":"2020","unstructured":"Yee PP, et al. Neutrophil-induced ferroptosis promotes tumor necrosis in glioblastoma progression. Nat Commun. 2020;11(1):5424.","journal-title":"Nat Commun"},{"issue":"1","key":"4340_CR87","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13045-023-01429-1","volume":"16","author":"D Wang","year":"2023","unstructured":"Wang D, et al. LCN2 secreted by tissue-infiltrating neutrophils induces the ferroptosis and wasting of adipose and muscle tissues in lung cancer cachexia. J Hematol Oncol. 2023;16(1):30.","journal-title":"J Hematol Oncol"},{"issue":"4","key":"4340_CR88","doi-asserted-by":"publisher","first-page":"e20201803","DOI":"10.1084\/jem.20201803","volume":"218","author":"F Veglia","year":"2021","unstructured":"Veglia F, et al. Analysis of classical neutrophils and polymorphonuclear myeloid-derived suppressor cells in cancer patients and tumor-bearing mice. J Exp Med. 2021;218(4):e20201803.","journal-title":"J Exp Med"},{"issue":"7939","key":"4340_CR89","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41586-022-05443-0","volume":"612","author":"R Kim","year":"2022","unstructured":"Kim R, et al. Ferroptosis of tumour neutrophils causes immune suppression in cancer. Nature. 2022;612(7939):338\u201346.","journal-title":"Nature"},{"issue":"6","key":"4340_CR90","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/j.cmet.2021.03.023","volume":"33","author":"SM Poznanski","year":"2021","unstructured":"Poznanski SM, et al. Metabolic flexibility determines human NK cell functional fate in the tumor microenvironment. Cell Metab. 2021;33(6):1205-1220.e5.","journal-title":"Cell Metab"},{"issue":"1","key":"4340_CR91","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13046-023-02629-w","volume":"42","author":"JX Cui","year":"2023","unstructured":"Cui JX, et al. L-kynurenine induces NK cell loss in gastric cancer microenvironment via promoting ferroptosis. J Exp Clin Cancer Res. 2023;42(1):52.","journal-title":"J Exp Clin Cancer Res"},{"key":"4340_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102923","volume":"67","author":"L Yao","year":"2023","unstructured":"Yao L, et al. Cancer-associated fibroblasts impair the cytotoxic function of NK cells in gastric cancer by inducing ferroptosis via iron regulation. Redox Biol. 2023;67:102923.","journal-title":"Redox Biol"},{"issue":"4","key":"4340_CR93","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.7150\/thno.89805","volume":"14","author":"Y Zhu","year":"2024","unstructured":"Zhu Y, et al. Cancer-associated fibroblasts reprogram cysteine metabolism to increase tumor resistance to ferroptosis in pancreatic cancer. Theranostics. 2024;14(4):1683\u2013700.","journal-title":"Theranostics"},{"issue":"24","key":"4340_CR94","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202300881","volume":"10","author":"F Jiang","year":"2023","unstructured":"Jiang F, et al. ANO1-mediated inhibition of cancer ferroptosis confers immunotherapeutic resistance through recruiting cancer-associated fibroblasts. Adv Sci (Weinh). 2023;10(24):e2300881.","journal-title":"Adv Sci (Weinh)"},{"key":"4340_CR95","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2023.100960","volume":"68","author":"R Qi","year":"2023","unstructured":"Qi R, et al. Cancer-associated fibroblasts suppress ferroptosis and induce gemcitabine resistance in pancreatic cancer cells by secreting exosome-derived ACSL4-targeting miRNAs. Drug Resist Updat. 2023;68:100960.","journal-title":"Drug Resist Updat"},{"issue":"1","key":"4340_CR96","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12943-020-01168-8","volume":"19","author":"H Zhang","year":"2020","unstructured":"Zhang H, et al. CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer. Mol Cancer. 2020;19(1):43.","journal-title":"Mol Cancer"},{"issue":"6","key":"4340_CR97","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1002\/ctm2.1300","volume":"13","author":"Z Shi","year":"2023","unstructured":"Shi Z, et al. Loss of LncRNA DUXAP8 synergistically enhanced sorafenib induced ferroptosis in hepatocellular carcinoma via SLC7A11 de-palmitoylation. Clinic Translat Med. 2023;13(6):1300.","journal-title":"Clinic Translat Med."},{"issue":"48","key":"4340_CR98","doi-asserted-by":"publisher","first-page":"33425","DOI":"10.1074\/jbc.M114.564567","volume":"289","author":"ND Yang","year":"2014","unstructured":"Yang ND, et al. Artesunate induces cell death in human cancer cells via enhancing lysosomal function and lysosomal degradation of ferritin. J Biol Chem. 2014;289(48):33425\u201341.","journal-title":"J Biol Chem"},{"issue":"1","key":"4340_CR99","doi-asserted-by":"publisher","first-page":"4485","DOI":"10.1038\/s41598-025-87628-x","volume":"15","author":"H Seddiek","year":"2025","unstructured":"Seddiek H, et al. Deferiprone ameliorates cisplatin induced peripheral neurotoxicity via ferritinophagy adjustment. Sci Rep. 2025;15(1):4485.","journal-title":"Sci Rep"},{"key":"4340_CR100","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1146\/annurev-pathmechdis-051122-094016","volume":"19","author":"H Jaeschke","year":"2024","unstructured":"Jaeschke H, Ramachandran A. Acetaminophen hepatotoxicity: paradigm for understanding mechanisms of drug-induced liver injury. Annu Rev Pathol. 2024;19:453\u201378.","journal-title":"Annu Rev Pathol"},{"issue":"2","key":"4340_CR101","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1007\/s10787-024-01439-6","volume":"32","author":"C Zhao","year":"2024","unstructured":"Zhao C, et al. Sulfasalazine promotes ferroptosis through AKT-ERK1\/2 and P53-SLC7A11 in rheumatoid arthritis. Inflammopharmacology. 2024;32(2):1277\u201394.","journal-title":"Inflammopharmacology"},{"issue":"5","key":"4340_CR102","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.chembiol.2019.01.008","volume":"26","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, et al. Imidazole Ketone Erastin Induces Ferroptosis and Slows Tumor Growth in a Mouse Lymphoma Model. Cell Chem Biol. 2019;26(5):623-633.e9.","journal-title":"Cell Chem Biol"},{"issue":"1","key":"4340_CR103","doi-asserted-by":"publisher","first-page":"8872","DOI":"10.1038\/s41598-023-35978-9","volume":"13","author":"JW Kim","year":"2023","unstructured":"Kim JW, et al. GPX4 overexpressed non-small cell lung cancer cells are sensitive to RSL3-induced ferroptosis. Sci Rep. 2023;13(1):8872.","journal-title":"Sci Rep"},{"issue":"3","key":"4340_CR104","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1002\/path.5882","volume":"257","author":"L Mart\u00edn-Saiz","year":"2022","unstructured":"Mart\u00edn-Saiz L, et al. Ferrostatin-1 modulates dysregulated kidney lipids in acute kidney injury. J Pathol. 2022;257(3):285\u201399.","journal-title":"J Pathol"},{"issue":"8067","key":"4340_CR105","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/s41586-025-08974-4","volume":"642","author":"T Ca\u00f1eque","year":"2025","unstructured":"Ca\u00f1eque T, et al. Activation of lysosomal iron triggers ferroptosis in cancer. Nature. 2025;642(8067):492\u2013500.","journal-title":"Nature"},{"issue":"4","key":"4340_CR106","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/s41419-023-05787-z","volume":"14","author":"TN Xavier da Silva","year":"2023","unstructured":"Xavier da Silva TN, et al. Molecular characterization of AIFM2\/FSP1 inhibition by iFSP1-like molecules. Cell Death Dis. 2023;14(4):281.","journal-title":"Cell Death Dis"},{"issue":"1","key":"4340_CR107","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.cell.2017.06.009","volume":"170","author":"DK Simanshu","year":"2017","unstructured":"Simanshu DK, Nissley DV, McCormick F. RAS proteins and their regulators in human disease. Cell. 2017;170(1):17\u201333.","journal-title":"Cell"},{"issue":"3","key":"4340_CR108","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S1535-6108(03)00050-3","volume":"3","author":"S Dolma","year":"2003","unstructured":"Dolma S, et al. Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells. Cancer Cell. 2003;3(3):285\u201396.","journal-title":"Cancer Cell"},{"issue":"7146","key":"4340_CR109","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/nature05859","volume":"447","author":"N Yagoda","year":"2007","unstructured":"Yagoda N, et al. RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels. Nature. 2007;447(7146):864\u20138.","journal-title":"Nature"},{"issue":"4","key":"4340_CR110","doi-asserted-by":"publisher","DOI":"10.1080\/23723556.2015.1054549","volume":"2","author":"Y Yu","year":"2015","unstructured":"Yu Y, et al. The ferroptosis inducer erastin enhances sensitivity of acute myeloid leukemia cells to chemotherapeutic agents. Mol Cell Oncol. 2015;2(4):e1054549.","journal-title":"Mol Cell Oncol"},{"key":"4340_CR111","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3389\/fonc.2015.00131","volume":"5","author":"C Schott","year":"2015","unstructured":"Schott C, et al. Oncogenic RAS Mutants Confer Resistance of RMS13 Rhabdomyosarcoma Cells to Oxidative Stress-Induced Ferroptotic Cell Death. Front Oncol. 2015;5:131.","journal-title":"Front Oncol"},{"issue":"6","key":"4340_CR112","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1158\/0008-5472.CAN-20-3477","volume":"81","author":"A Ghoochani","year":"2021","unstructured":"Ghoochani A, et al. Ferroptosis inducers are a novel therapeutic approach for advanced prostate cancer. Cancer Res. 2021;81(6):1583\u201394.","journal-title":"Cancer Res"},{"issue":"3","key":"4340_CR113","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.chembiol.2008.02.010","volume":"15","author":"WS Yang","year":"2008","unstructured":"Yang WS, Stockwell BR. Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring cancer cells. Chem Biol. 2008;15(3):234\u201345.","journal-title":"Chem Biol"},{"key":"4340_CR114","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102703","volume":"62","author":"DM Cheff","year":"2023","unstructured":"Cheff DM, et al. The ferroptosis inducing compounds RSL3 and ML162 are not direct inhibitors of GPX4 but of TXNRD1. Redox Biol. 2023;62:102703.","journal-title":"Redox Biol"},{"issue":"4","key":"4340_CR115","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1002\/1873-3468.13631","volume":"594","author":"AM Vu\u010dkovi\u0107","year":"2020","unstructured":"Vu\u010dkovi\u0107 AM, et al. Inactivation of the glutathione peroxidase GPx4 by the ferroptosis-inducing molecule RSL3 requires the adaptor protein 14-3-3\u03b5. FEBS Lett. 2020;594(4):611\u201324.","journal-title":"FEBS Lett"},{"issue":"3","key":"4340_CR116","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1159\/000327563","volume":"29","author":"HY Kim","year":"2011","unstructured":"Kim HY, Park JW. Molecularly targeted therapies for hepatocellular carcinoma: sorafenib as a stepping stone. Dig Dis. 2011;29(3):303\u20139.","journal-title":"Dig Dis"},{"key":"4340_CR117","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2023.175913","volume":"955","author":"Q Li","year":"2023","unstructured":"Li Q, et al. Understanding sorafenib-induced ferroptosis and resistance mechanisms: implications for cancer therapy. Eur J Pharmacol. 2023;955:175913.","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"4340_CR118","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13158","volume":"55","author":"S Yuan","year":"2022","unstructured":"Yuan S, et al. Sorafenib attenuates liver fibrosis by triggering hepatic stellate cell ferroptosis via HIF-1\u03b1\/SLC7A11 pathway. Cell Prolif. 2022;55(1):e13158.","journal-title":"Cell Prolif"},{"issue":"6","key":"4340_CR119","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1007\/s10120-017-0720-y","volume":"20","author":"K Shitara","year":"2017","unstructured":"Shitara K, et al. Phase 1 study of sulfasalazine and cisplatin for patients with CD44v-positive gastric cancer refractory to cisplatin (EPOC1407). Gastric Cancer. 2017;20(6):1004\u20139.","journal-title":"Gastric Cancer"},{"key":"4340_CR120","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2020.107706","volume":"216","author":"Y Augustin","year":"2020","unstructured":"Augustin Y, Staines HM, Krishna S. Artemisinins as a novel anti-cancer therapy: targeting a global cancer pandemic through drug repurposing. Pharmacol Ther. 2020;216:107706.","journal-title":"Pharmacol Ther"},{"issue":"10130","key":"4340_CR121","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1016\/S0140-6736(18)30324-6","volume":"391","author":"EA Ashley","year":"2018","unstructured":"Ashley EA, Pyae Phyo A, Woodrow CJ. Malaria. Lancet. 2018;391(10130):1608\u201321.","journal-title":"Lancet"},{"issue":"11","key":"4340_CR122","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.phymed.2015.08.002","volume":"22","author":"E Ooko","year":"2015","unstructured":"Ooko E, et al. Artemisinin derivatives induce iron-dependent cell death (ferroptosis) in tumor cells. Phytomedicine. 2015;22(11):1045\u201354.","journal-title":"Phytomedicine"},{"issue":"1","key":"4340_CR123","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/s41418-019-0352-3","volume":"27","author":"GQ Chen","year":"2020","unstructured":"Chen GQ, et al. Artemisinin compounds sensitize cancer cells to ferroptosis by regulating iron homeostasis. Cell Death Differ. 2020;27(1):242\u201354.","journal-title":"Cell Death Differ"},{"issue":"1","key":"4340_CR124","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1172\/JCI73939","volume":"125","author":"YC Kim","year":"2015","unstructured":"Kim YC, Guan KL. mTOR: a pharmacologic target for autophagy regulation. J Clin Invest. 2015;125(1):25\u201332.","journal-title":"J Clin Invest"},{"issue":"16","key":"4340_CR125","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2315541121","volume":"121","author":"H Li","year":"2024","unstructured":"Li H, et al. USP8-governed GPX4 homeostasis orchestrates ferroptosis and cancer immunotherapy. Proc Natl Acad Sci U S A. 2024;121(16):e2315541121.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"4340_CR126","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/s41392-024-01772-w","volume":"9","author":"L Ma","year":"2024","unstructured":"Ma L, et al. Targeting carnitine palmitoyl transferase 1A (CPT1A) induces ferroptosis and synergizes with immunotherapy in lung cancer. Signal Transduct Target Ther. 2024;9(1):64.","journal-title":"Signal Transduct Target Ther"},{"issue":"23","key":"4340_CR127","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202310309","volume":"11","author":"Y Li","year":"2024","unstructured":"Li Y, et al. Nanoparticles synergize ferroptosis and cuproptosis to potentiate cancer immunotherapy. Adv Sci (Weinh). 2024;11(23):e2310309.","journal-title":"Adv Sci (Weinh)"},{"issue":"11","key":"4340_CR128","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1093\/bbb\/zbad117","volume":"87","author":"N Usukhbayar","year":"2023","unstructured":"Usukhbayar N, Uesugi S, Kimura KI. 3,6-Epidioxy-1,10-bisaboladiene and sulfasalazine synergistically induce ferroptosis-like cell death in human breast cancer cell lines. Biosci Biotechnol Biochem. 2023;87(11):1336\u201344.","journal-title":"Biosci Biotechnol Biochem"},{"issue":"2","key":"4340_CR129","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/s41401-020-0478-3","volume":"42","author":"ZJ Li","year":"2021","unstructured":"Li ZJ, et al. Artesunate synergizes with sorafenib to induce ferroptosis in hepatocellular carcinoma. Acta Pharmacol Sin. 2021;42(2):301\u201310.","journal-title":"Acta Pharmacol Sin"},{"key":"4340_CR130","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2024.116670","volume":"276","author":"W Huang","year":"2024","unstructured":"Huang W, et al. Ferroptosis-inducing compounds synergize with docetaxel to overcome chemoresistance in docetaxel-resistant non-small cell lung cancer cells. Eur J Med Chem. 2024;276:116670.","journal-title":"Eur J Med Chem"},{"issue":"6","key":"4340_CR131","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.trecan.2021.01.013","volume":"7","author":"TA Mishchenko","year":"2021","unstructured":"Mishchenko TA, et al. Ferroptosis and photodynamic therapy synergism: Enhancing anticancer treatment. Trends Cancer. 2021;7(6):484\u20137.","journal-title":"Trends Cancer"},{"issue":"11","key":"4340_CR132","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1007\/s13238-021-00841-y","volume":"12","author":"G Lei","year":"2021","unstructured":"Lei G, et al. Ferroptosis, radiotherapy, and combination therapeutic strategies. Protein Cell. 2021;12(11):836\u201357.","journal-title":"Protein Cell"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-026-04340-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-026-04340-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-026-04340-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T12:02:32Z","timestamp":1790164952000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-026-04340-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":132,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["4340"],"URL":"https:\/\/doi.org\/10.1007\/s12094-026-04340-6","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,30]]},"assertion":[{"value":"29 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All of the authors have consented to participate.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All of the authors have consented to the publication of the text.","order":4,"name":"Ethics","label":"Consent to publish","group":{"name":"EthicsHeading","label":"Declarations"}}]}}